Average Co-Inventor Count = 5.91
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck + Co., Inc. (19 from 4,770 patents)
2. Merck Sharp + Dohme Corp. (7 from 2,405 patents)
3. Arena Pharmaceuticals, Inc. (1 from 216 patents)
4. Merck Sharpe & Dohme Corp. (1 from 35 patents)
27 patents:
1. 10568876 - Tetrahydroisoquinoline derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2
2. 10472344 - Factor XIa inhibitors
3. 9877957 - Tetrahydroisoquinoline derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2
4. 9828369 - Isoquinoline derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2
5. 8637555 - Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof
6. 8318760 - Substituted aryl and heteroaryl derivatives, compositions containing such compounds and methods of use
7. 8168649 - Niacin receptor agonists, compositions containing such compounds and methods of treatment
8. 7968589 - Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
9. 7687534 - Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
10. 7411073 - Selective non-steroidal glucocorticoid receptor modulators
11. 7196106 - Cyanothiophene derivatives, compositions containing such compounds and methods of use
12. 6642237 - Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides and uses thereof
13. 6589962 - Alpha-hydroxy-gamma-[[(carbocyclic-or heterocyclic-substituted)amino]carbonyl]alkanamide derivatives and uses thereof
14. 6420376 - Amido spiropiperidines promote the release of growth hormone
15. 6063796 - Somatostatin agonists